Crossmark

Dry eye symptoms and impact on vision-related function across International Task Force guidelines severity levels in the United States

Crossref DOI link: https://doi.org/10.1186/s12886-018-0919-7

Published Online: 2018-09-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Barber, Laurie

Khodai, Omid

Croley, Thomas

Lievens, Christopher

Montaquila, Stephen

Ziemanski, Jillian

McCart, Melissa

Lunacsek, Orsolya

Burk, Caroline

Patel, Vaishali
Funding

Funding for this research was provided by:

Allergan
License Information

Text and Data Mining valid from 2018-09-29
More Information

Article History

Received: 18 October 2017

Accepted: 11 September 2018

First Online: 29 September 2018

Ethics approval and consent to participate

: The study protocol was approved by an independent ethics committee at each of the 10 study sites. All patients provided their written informed consent prior to study participation.

: Not applicable.

: LB and SM were consultants for the study. OK and TC declare that they have no conflicts of interest to disclose. JZ has served as a consultant to Allergan plc. CL has served as an advisor to Allergan plc. MM and OL are employees of Xcenda, which has received fees for data and statistical analysis from Allergan plc. CB is a consultant to Allergan plc. VP is an employee of Allergan plc.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.